These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 26385102)

  • 1. Recurrent acute coronary syndrome and restenosis after percutaneous coronary intervention in a patient with idiopathic thrombocytopenic purpura: a case report and literature review.
    Li-Sha G; Peng C; Yue-Chun L
    BMC Cardiovasc Disord; 2015 Sep; 15():101. PubMed ID: 26385102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous coronary intervention in a patient with immune thrombocytopenia purpura.
    Stouffer GA; Hirmerova J; Moll S; Rubery B; Napoli M; Ohman EM; Simpson R
    Catheter Cardiovasc Interv; 2004 Mar; 61(3):364-7. PubMed ID: 14988897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic thrombocytopenic purpura and percutaneous coronary stenting: a dangerous duo?
    Moretti C; Teresa Lucciola M; Morena L; Biondi-Zoccai G; Laudito A; Anselmino M; Paolo Trevi G; Sheiban I
    Int J Cardiol; 2008 Nov; 130(3):e96-7. PubMed ID: 17854925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiplatelet treatment after percutaneous coronary intervention in a patient with idiopathic thrombocytopenic purpura].
    Can MM; Tanboğa IH; Boztosun B; Kaymaz C
    Turk Kardiyol Dern Ars; 2009 Dec; 37(8):575-7. PubMed ID: 20200462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of intense antithrombotic treatment and percutaneous coronary intervention deferral in patients with large intracoronary thrombus.
    Echavarría-Pinto M; Lopes R; Gorgadze T; Gonzalo N; Hernández R; Jiménez-Quevedo P; Alfonso F; Bañuelos C; Nuñez-Gil IJ; Ibañez B; Fernández C; Fernandez-Ortiz A; García E; Macaya C; Escaned J
    Am J Cardiol; 2013 Jun; 111(12):1745-50. PubMed ID: 23528026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive management of non-ST elevation myocardial infarction (NSTEMI) in a patient with severe thrombocytopenia secondary to adult-onset immune thrombocytopenic purpura.
    Shah MU; Muhammad A; Davison B; Naqvi SY
    BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36549758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet therapy and percutaneous coronary intervention in patients with acute coronary syndrome and thrombocytopenia.
    Yusuf SW; Iliescu C; Bathina JD; Daher IN; Durand JB
    Tex Heart Inst J; 2010; 37(3):336-40. PubMed ID: 20548817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiographic outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes).
    Kunadian V; James SK; Wojdyla DM; Zorkun C; Wu J; Storey RF; Steg PG; Katus H; Emanuelsson H; Horrow J; Maya J; Wallentin L; Harrington RA; Gibson CM
    JACC Cardiovasc Interv; 2013 Jul; 6(7):671-83. PubMed ID: 23866179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet intervention in acute coronary syndrome.
    Arora RR; Rai F
    Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
    Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
    JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
    Pride YB; Wiviott SD; Buros JL; Zorkun C; Tariq MU; Antman EM; Braunwald E; Gibson CM;
    Am Heart J; 2009 Sep; 158(3):e21-6. PubMed ID: 19699846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
    Spinler SA
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of final activated clotting time after transradial coronary stenting with maximal antiplatelet therapy.
    Bertrand OF; Rodés-Cabau J; Rinfret S; Larose E; Bagur R; Proulx G; Gleeton O; Costerousse O; De Larochellière R; Roy L
    Am J Cardiol; 2009 Nov; 104(9):1235-40. PubMed ID: 19840568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from the Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty [ARMYDA-8 RELOAD-ACS] trial).
    Patti G; Pasceri V; Mangiacapra F; Colonna G; Vizzi V; Ricottini E; Montinaro A; D'Ambrosio A; Wijns W; Barbato E; Di Sciascio G;
    Am J Cardiol; 2013 Jul; 112(2):162-8. PubMed ID: 23601577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes.
    Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
    Catheter Cardiovasc Interv; 2010 Oct; 76(4):513-24. PubMed ID: 20882655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary revascularization in a patient with immune thrombocytopenic purpura.
    Fong MC; Chen KC; Leu HB; Chen LC
    J Chin Med Assoc; 2006 Sep; 69(9):436-8. PubMed ID: 17051755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late outcomes after drug-eluting stent implantation in "real-world" clinical practice.
    Ramsdale DR; Rao A; Asghar O; Ramsdale KA; McKay E
    J Invasive Cardiol; 2008 Oct; 20(10):493-500. PubMed ID: 18829991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary PCI for acute myocardial infarction in a patient with idiopathic thrombocytopenic purpura. A case report and review of the literature.
    Neskovic AN; Stankovic I; Milicevic P; Aleksic A; Vlahovic-Stipac A; Calija B; Putnikovic B
    Herz; 2010 Jan; 35(1):43-9. PubMed ID: 20140789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of prasugrel and clopidogrel-treated patients with acute coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis of the Acute Myocardial Infarction in Switzerland (AMIS)-Plus Registry.
    Kurz DJ; Radovanovic D; Seifert B; Bernheim AM; Roffi M; Pedrazzini G; Windecker S; Erne P; Eberli FR
    Eur Heart J Acute Cardiovasc Care; 2016 Feb; 5(1):13-22. PubMed ID: 25614494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Percutaneous Coronary Intervention by a Stentless Technique for Acute Myocardial Infarction with Idiopathic Thrombocytopenic Purpura: A Case Report and Review of the Literature.
    Fujino S; Niwa S; Fujioka K; Mabuchi T; Noji Y; Yamaguchi M; Aoyama T
    Intern Med; 2016; 55(2):147-52. PubMed ID: 26781014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.